在越南人口中探索LDLR-APOB在家族高胆固醇血症中的相互作用:一种蛋白质-蛋白质对接方法
Ngoc-Thanh Kim1,2, Doan-Loi Do1,2, Mai-Ngoc Thi Nguyen2
1Department of Cardiology, Hanoi Medical University, Hanoi, Vietnam.
Bioinformatics and biology insights
|December 2, 2024
概括
这项研究在越南人群中发现了LDLR和APOB基因的新突变,揭示了与动脉样硬化心血管疾病 (CVD) 和家族高胆固醇血症 (FH) 相关的有害蛋白质相互作用.
科学领域:
- 遗传学和分子生物学
- 心血管研究研究心血管研究
- 生物信息学是一种生物信息学.
背景情况:
- 动脉样性心血管疾病 (CVD) 受到遗传因素的显著影响,包括低密度脂蛋白受体 (LDLR) 和阿波利波蛋白B (APOB) 基因的突变,这是家族性高胆固醇血症 (FH) 的常见原因.
- 了解特定的遗传变异及其在不同人群中的分子影响,如越南人群,对于准确的诊断和向治疗至关重要.
研究的目的:
- 确定越南人口中的新型LDLR和APOB突变,并阐明它们对心血管疾病 (CVD) 发展的影响.
- 通过计算建模和分子对接,研究这些突变对蛋白质-蛋白质相互作用的结构和功能后果.
主要方法:
- 综合生物信息分析以检测新的LDLR和APOB突变.
- 同质模型用于预测野生类型和突变蛋白质的3D结构.
- 蛋白质-蛋白质分子对接,以评估突变对LDLR和APOB之间的结合亲和关系的影响.
主要成果:
- 在LDLR中识别了10种新的结合残留物,包括ASP-47,GLY-48和GLU-51.
- 对154个蛋白质复合体的分析揭示了5种特定的突变异型 (APOB-LDLR),表现出低结合亲和度和显著的结合相互作用.
- 检测到潜在的有害相互作用,例如APOB (Arg3527Trp) -LDLR (Cys318Arg) 和APOB (His3583Leu) -LDLR (Cys104Tyr). 检测到可能有害的相互作用,例如APOB (Arg3527Trp) -LDLR (Cys318Arg) 和APOB (His3583Leu) -LDLR (Cys104Tyr).
结论:
- 鉴定出新的突变及其产生的蛋白相互作用为我们提供了关于CVD和FH背后的分子机制的见解.
- 这些发现突出了对治疗动脉样硬化心血管疾病的潜在治疗点.
- 这项研究增强了对FH遗传变异的理解,并可以指导未来在该领域的研究.
相关概念视频
Lipid-Lowering Drugs: Statins and Miscellaneous Agents
532
Hyperlipidemia, a medical condition often referred to as high cholesterol, is characterized by abnormally elevated levels of lipids in the bloodstream. When present in excess, these lipids, specifically cholesterol and triglycerides, can lead to serious health complications, often involving cardiovascular diseases. Illnesses like atherosclerosis, heart attacks, and pancreatitis have all been linked to untreated hyperlipidemia. This means controlling and regulating cholesterol and triglyceride...
532
Factors Affecting Protein-Drug Binding: Drug Interactions
104
Drug interactions are a critical aspect of pharmacology and can occur when two or more drugs compete for the same binding site. This competition can result in one drug displacing another, altering the effect of the displaced drug. Drug interactions are complex processes that rely heavily on how much of the displacer drug is present and how strongly it can bind to the same sites as the displaced drug.
Displacement interactions can have varying outcomes, ranging from toxicity to virtually...
Displacement interactions can have varying outcomes, ranging from toxicity to virtually...
104
Ligand Binding and Linkage
4.8K
Allosteric proteins have more than one ligand binding site; the binding of a ligand to any of these sites influences the binding of ligands to the other sites. When a protein is allosteric, its binding sites are called coupled or linked. In the case of enzymes, the site that binds to the substrate is known as the active site and the other site is known as the regulatory site. When a ligand binds to the regulatory site, this leads to conformational changes in the protein that can influence...
4.8K
Protein-protein Interfaces
12.5K
Many proteins form complexes to carry out their functions, making protein-protein interactions (PPIs) essential for an organism's survival. Most PPIs are stabilized by numerous weak noncovalent chemical forces. The physical shape of the interfaces determines the way two proteins interact. Many globular proteins have closely-matching shapes on their surfaces, which form a large number of weak bonds. Additionally, many PPIs occur between two helices or between a surface cleft and a...
12.5K
Ligand Binding Sites
12.7K
Proteins are dynamic macromolecules that carry out a wide variety of essential processes; however, the activities of most proteins depend on their interactions with other molecules or ions, known as ligands.
Protein-ligand interactions are quite specific; even though numerous potential ligands surround a cellular protein at any given time, only a particular ligand can bind to that protein. Moreover, a ligand binds only to a dedicated area on the surface of the protein, known as the...
Protein-ligand interactions are quite specific; even though numerous potential ligands surround a cellular protein at any given time, only a particular ligand can bind to that protein. Moreover, a ligand binds only to a dedicated area on the surface of the protein, known as the...
12.7K


